IHC - Inhibin Alpha

The IHC – Inhibin Alpha test is an advanced immunohistochemistry (IHC) diagnostic test used to detect Inhibin Alpha protein expression in tissue samples. Inhibin Alpha is a hormone-related glycoprotein normally produced by cells of the ovaries, testes, placenta, and adrenal glands. Its detection in tissue plays an important role in identifying specific tumors of gonadal and endocrine origin.

This test is commonly used in pathology laboratories to help diagnose ovarian sex cord-stromal tumors, adrenal cortical tumors, and certain gonadal neoplasms. It is especially valuable in distinguishing these tumors from other cancers with similar microscopic appearances.

The Inhibin Alpha test is often performed as part of a panel of immunohistochemical markers to confirm tumor origin and improve diagnostic accuracy.

Benefits of the Test

The IHC Inhibin Alpha test offers several important benefits:

• Detects Inhibin Alpha protein expression in tissue
• Helps identify ovarian granulosa cell tumors
• Supports diagnosis of adrenal cortical tumors
• Differentiates gonadal tumors from other neoplasms
• Improves accuracy in complex tumor classification
• Guides personalized treatment planning

This test is highly valuable when routine histopathology findings are inconclusive.

Why Doctors Recommend This Test

Doctors recommend the Inhibin Alpha IHC test when there is suspicion of tumors arising from ovarian sex cord-stromal cells, adrenal cortex, or gonadal tissues.

It is commonly ordered in cases involving:

• Suspected granulosa cell tumors of the ovary
• Adrenal cortical adenomas or carcinomas
• Gonadal stromal tumors
• Tumors of unclear endocrine origin
• Cases requiring advanced pathological confirmation

The test helps pathologists confirm diagnosis and assists oncologists in planning appropriate treatment strategies.

Preparation Before Test

No special preparation is required from the patient. The test is performed on tissue biopsy or surgical specimens already collected during routine diagnostic procedures.

Normal Reporting Time

The usual reporting time for the Inhibin Alpha IHC test is 2 to 4 working days, depending on sample processing and laboratory workflow.

Who Should Take This Test

This test is recommended for:

• Patients with suspected ovarian stromal tumors
• Individuals with adrenal gland tumors
• Patients with gonadal neoplasms
• Cases needing endocrine tumor confirmation
• Oncology patients undergoing tumor origin analysis

The IHC Inhibin Alpha test is an essential diagnostic tool in modern pathology. It helps accurately identify specific endocrine and gonadal tumors, ensuring precise diagnosis and supporting better treatment decisions. Early and accurate detection significantly improves patient management and clinical outcomes.